Evidence map›Paper›PMID 36354429›Full record

ArticleBiosensors2022

Construction of Aptamer-Based Nanobiosensor for Breast Cancer Biomarkers Detection Utilizing g-C

Mehrab Pourmadadi, Fatemeh Yazdian, Sohrabali Ghorbanian, Amin Shamsabadipour, Elham Khandel, Hamid Rashedi, Abbas Rahdar, Ana M Díez-Pascual

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehrab PourmadadiDepartment of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.ORCID 0000-0002-8819-3649
Fatemeh YazdianDepartment of Life Science Engineering, Faculty of New Science and Technology, University of Tehran, Tehran 14166-34793, Iran.
Sohrabali GhorbanianSchool of Chemical Engineering, College of Engineering, University of Tehran, Tehran 14166-34793, Iran.
Amin ShamsabadipourDepartment of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.ORCID 0000-0001-9920-4764
Elham KhandelDepartment of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.
Hamid RashediDepartment of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran.ORCID 0000-0002-8460-0841
Abbas RahdarDepartment of Physics, Faculty of Science, University of Zabol, Zabol 538-98615, Iran.ORCID 0000-0003-4766-9214
Ana M Díez-PascualUniversidad de Alcalá, Facultad de Ciencias, Departamento de Química Analítica, Química Física e Ingeniería Química, Ctra. Madrid-Barcelona, Km. 33.6, 28805 Alcalá de Henares, Madrid, Spain.ORCID 0000-0001-7405-2354

Funding

Comunidad de Madrid EPV/012
6 · The paper itself

Abstract

An electrochemical aptasensor has been developed to determine breast cancer biomarkers (CA 15-3). Aptamer chains were immobilized on the surface of the electrode by g-C

Indexed as

Aptamers, NucleotideBiosensing TechniquesBreast NeoplasmsGraphiteNanoparticlesBiomarkers, TumorElectrochemical TechniquesElectrodesFemaleGoldHumansLimit of DetectionMagnetic PhenomenaAptamers, NucleotideBiomarkers, TumorGoldGraphiteaptamerbiomarkerbiosensorbreast cancerg-C3N4nanomaterial

Identifiers

PMID36354429
PMCPMC9688306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.